MINT-INDOMETHACIN DIN 02461536
Health Canada record
| Active ingredient(s) | INDOMETHACIN 50 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AB01 INDOMETACIN |
| Original market date | 03-Apr-2017 |
| Current status date | 03-Apr-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mint Pharmaceuticals Inc — licence 101613, currently licensed, last inspection rating C (2023-01-16).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INDOMETHACIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02499223 | AURO-INDOMETHACIN | AURO PHARMA INC | Capsule | INDOMETHACIN 50 MG | Marketed |
| 02461811 | MINT-INDOMETHACIN | MINT PHARMACEUTICALS INC | Capsule | INDOMETHACIN 25 MG | Marketed |
| 02231800 | ODAN-INDOMETHACIN | ODAN LABORATORIESLTD | Suppository | INDOMETHACIN 100 MG | Marketed |
| 02231799 | ODAN-INDOMETHACIN | ODAN LABORATORIESLTD | Suppository | INDOMETHACIN 50 MG | Marketed |
| 00337420 | TEVA-INDOMETHACIN | TEVA CANADA LIMITED | Capsule | INDOMETHACIN 25 MG | Marketed |
| 00337439 | TEVA-INDOMETHACIN | TEVA CANADA LIMITED | Capsule | INDOMETHACIN 50 MG | Marketed |
| 00611166 | APO-INDOMETHACIN | APOTEX INC | Capsule | INDOMETHACIN 50 MG | Dormant |
| 00611158 | APO-INDOMETHACIN | APOTEX INC | Capsule | INDOMETHACIN 25 MG | Dormant |
| 02238442 | FTP-INDOMETHACIN | FTP-PHARMACAL INC. | Capsule | INDOMETHACIN 25 MG | Cancelled Post Market |
| 02238443 | FTP-INDOMETHACIN | FTP-PHARMACAL INC. | Capsule | INDOMETHACIN 50 MG | Cancelled Post Market |
| 00016039 | INDOCID CAP 25MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Capsule | INDOMETHACIN 25 MG | Cancelled Post Market |
| 00016047 | INDOCID CAP 50MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Capsule | INDOMETHACIN 50 MG | Cancelled Post Market |
| 00463248 | INDOCID SR 75MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Capsule (Sustained-Release) | INDOMETHACIN 75 MG | Cancelled Post Market |
| 00594458 | INDOCID STERILE OPH SUSP 1% | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Drops | INDOMETHACIN 10 MG | Cancelled Post Market |
| 00016233 | INDOCID SUP 100MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Suppository | INDOMETHACIN 100 MG | Cancelled Post Market |
| 00594466 | INDOCID SUP 50MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Suppository | INDOMETHACIN 50 MG | Cancelled Post Market |
| 02219506 | INDOCOLLYRE | LABORATOIRE CHAUVIN S.A. | Powder For Solution; Liquid | INDOMETHACIN 1 MG | Cancelled Post Market |
| 02176149 | NOVO-METHACIN - 100MG SUP | NOVOPHARM LIMITED | Suppository | INDOMETHACIN 100 MG | Cancelled Post Market |
| 02176130 | NOVO-METHACIN - SUP 50MG | NOVOPHARM LIMITED | Suppository | INDOMETHACIN 50 MG | Cancelled Post Market |
| 02348322 | NTP-INDOMETHACIN | TEVA CANADA LIMITED | Capsule | INDOMETHACIN 25 MG | Cancelled Pre Market |
| 02348330 | NTP-INDOMETHACIN | TEVA CANADA LIMITED | Capsule | INDOMETHACIN 50 MG | Cancelled Pre Market |
| 00865850 | NU-INDO CAP 25MG | NU-PHARM INC | Capsule | INDOMETHACIN 25 MG | Cancelled Post Market |
| 00865869 | NU-INDO CAP 50MG | NU-PHARM INC | Capsule | INDOMETHACIN 50 MG | Cancelled Post Market |
| 00646261 | PRO-INDO 25 CAP 25MG | PRO DOC LIMITEE | Capsule | INDOMETHACIN 25 MG | Cancelled Post Market |
| 00646288 | PRO-INDO 50 CAP 50MG | PRO DOC LIMITEE | Capsule | INDOMETHACIN 50 MG | Cancelled Post Market |
| 01934139 | RATIO-INDOMETHACIN | TEVA CANADA LIMITED | Suppository | INDOMETHACIN 100 MG | Cancelled Post Market |
| 02143372 | RATIO-INDOMETHACIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Capsule | INDOMETHACIN 50 MG | Cancelled Post Market |
| 02143364 | RATIO-INDOMETHACIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Capsule | INDOMETHACIN 25 MG | Cancelled Post Market |
| 01934147 | RATIO-INDOMETHACIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Suppository | INDOMETHACIN 50 MG | Cancelled Post Market |
| 02204541 | RHODACINE - CAP 25MG | RHODIAPHARM INC | Capsule | INDOMETHACIN 25 MG | Cancelled Post Market |
| 02204568 | RHODACINE - CAP 50MG | RHODIAPHARM INC | Capsule | INDOMETHACIN 50 MG | Cancelled Post Market |
| 02146940 | RHODACINE - SUP 100MG | RHOXALPHARMA INC | Suppository | INDOMETHACIN 100 MG | Cancelled Post Market |
| 02146932 | RHODACINE - SUP 50MG | RHOXALPHARMA INC | Suppository | INDOMETHACIN 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18986 | 2017-02-17 | Abbreviated New Drug Submission (ANDS) |
International API supply for INDOMETHACIN
10 active FDA Drug Master Files.
Request a quote for MINT-INDOMETHACIN